Harry Lamble

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Spinomix SA develops a software technology platform. The private company is based in Lausanne, Switzerland and has subsidiaries in Switzerland.

New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY.

The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators.

Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO.

Roche Diagnostics develops test and diagnostic solutions in vitro to serve the patients. The company was founded on February 4, 1991 and is headquartered in Meylan, France.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

BioHelix Corp. operates as a molecular diagnostic company, that develops nucleic acid technologies for molecular diagnostics. The firm focuses on the development of simple molecular diagnostic tests for the near patient setting. It offers in vitro diagnostic products, such as IsoAmp, an herpes simplex viruses (HSV) assay test for the direct, qualitative detection of HSV DNA in male and female genital and oral lesions. The company was founded by Huimin Kong in 2004 and is headquartered in Beverly, MA.

Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA.

HistoRx, Inc. develops tissue-based diagnostic products. The company was founded on July 23, 2004 and is headquartered in Carlsbad, CA.

Stratos Genomics, Inc. develops nucleic acid sequencing methods. The firm's Sequencing by Expansion (SBX) solution offers a single-molecule detection process that allows whole genome sequencing. The company was founded by Allan H. Stephan, Mark Kokoris, and Robert McRuer in 2007 and is headquartered in Seattle, WA.

Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA.

BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA.

Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

Buckman Laboratories SARL wholesales chemicals to the paint industry. The firm markets its products under the brand names such as BUCKMAN, BUFLOC, BULAB, BUSAN, BUSPERSE, and BUTROL. The company was founded on December 21, 2007 and is headquartered in Wasquehal, France.

Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021.

Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom.

Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom.

Proteorex Therapeutics, Inc. develops novel therapeutics. It is discovering small-molecule drugs to treat diseases with the greatest unmet medical need. The firm’s drug discovery platform integrates a novel synthesis design strategy, machine learning, and patient-derived cell-based screening to unlock targets considered undruggable using existing approaches. The company was founded by Aman Iqbal, Kong T. Nguyen, Robert Batey and Michael Anstey and is headquartered in Toronto, Canada.

Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom.

FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV.

Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom.

MOBILion Systems, Inc. offers paradigm-shifting platform technology. It will Develop a cost effective analytical system with a small footprint, high throughput, ultra-high sensitivity and selectivity enabling use in commercial applications unattainable by conventional ion mobility separation devices. The company was founded in 2015 and is headquartered in , Chadds Ford, PA.

Apton Biosystems, Inc. engages in the provision of health care services with focus on biotechnology business. The company was founded in 2012 and is headquartered in Pleasanton, CA.

GestVision, Inc. provides care diagnostic test for preeclampsia. The firm delivers insights for safer pregnancies beginning with a diagnostic for preeclampsia, a poorly understood pregnancy- related condition. It is developing a point of care diagnostic product that provides essential information to OBGYNs for improving patient management and outcomes. The company was founded in 2014 by Wendy L. Davis and is headquartered in Groton, CT.

Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel.

MedCision LLC provides medical related software solutions. Its products include ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems and Custom ULT Freezer Storage Boxes. The firm develops and commercializes technologies that automate and standardize preclinical and clinical biologics handling for critical post-manufacturing processes. The company was founded by Rolf O. Ehrhardt in 2016 and is headquartered in San Rafael, CA.